Drug Shortage Report for CARBAMAZEPINE CR
Report ID | 102148 |
Drug Identification Number | 02413604 |
Brand name | CARBAMAZEPINE CR |
Common or Proper name | CARBAMAZEPINE CR |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CARBAMAZEPINE |
Strength(s) | 400MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-02-12 |
Actual start date | |
Estimated end date | |
Actual end date | 2020-03-11 |
Shortage status | Resolved |
Updated date | 2020-03-12 |
Company comments | Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-03-12 | English | Compare |
v5 | 2020-03-11 | French | Compare |
v4 | 2020-03-11 | English | Compare |
v3 | 2020-02-13 | English | Compare |
v2 | 2020-01-03 | French | Compare |
v1 | 2020-01-03 | English | Compare |
Showing 1 to 6 of 6